abstract |
The present invention relates to the use of a Podotti mode, or a physiologically acceptable salt thereof, for the treatment of irritable bowel syndrome. For the treatment of the present invention, the PDT mode, or a physiologically acceptable salt thereof, may be administered via the oral route or rectum. |